Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study

David Scott Miller, John A. Blessing, Steven Waggoner, Jeanne Schilder, Joel Sorosky, Jeffrey Bloss, Russell Schilder

Research output: Contribution to journalArticle

19 Scopus citations

Fingerprint Dive into the research topics of 'Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences